We’re proud to say that UK blood cancer research truly leads the world, thanks to the money we’ve been able to invest because of you.
Today, two-thirds of everyone diagnosed with blood cancer will still be with us in five years’ time. In 1960, almost everyone died of their disease eventually.
It’s amazing to realise that many major advances in cancer medicine have come first from blood cancer research, so together we’re changing lives even beyond blood cancer. It was blood cancer research that proved that chemotherapy could be used to treat cancer: a finding that’s given hope to millions of people across the world.
Our impact is plain to see: where we’ve invested, survival rates and quality of life have improved. Here’s a snapshot of some of the things we’ve done - with your help - that have changed the world for people with blood cancer.
Potentially life-saving new treatments were taking up to 10 years to get to patients, because some clinical trials used to happen very slowly. So we set up our Trials Acceleration Programme (TAP) to speed them up and get new treatments to more patients, more quickly.